General Information
DRAVP ID DRAVPe00660
Peptide Name LP-65
Sequence IEELLKKAEEQQKKNEEELKKLEX
Sequence Length 24
UniProt ID P03377
Source Synthetic construct
Activity Information
Target Organism HIV
Assay cell-fusion assay,single-cycle infection assay
Activity
Hemolytic Activity No hemolysis information or data found in the reference(s) presented in this entry
Cytotoxicity
Binding Target membrane
Mechanism The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)
Structure Information
PDB ID None
Predicted Structure Download No predicted structure available
Linear/Cyclic Linear
N-terminal Modification Acetylation
C-terminal Modification Amidation
Other Modification The 'X' at position 24 is Lys-C16(palmitic acid)
Stereochemistry L
Physicochemical Information
Formula C123H210N32O42
Absent amino acids CDFGHMPRSTVWY
Common amino acids E
Mass 2938.56
Pl 4.94
Basic residues 6
Acidic residues 8
Hydrophobic residues 6
Net charge -2
Boman Index -7909
Hydrophobicity -168.33
Aliphatic Index 85.42
Half Life
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 1
Literature Information
Literature 1
Title Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.
Pubmed ID 30089693
Reference J Virol. 2018 Sep 26;92(20):e01088-18.
Author Chong H, Zhu Y, Yu D, He Y.